The invention relates to the field of biological
pharmacy, and discloses a method for forming and transforming
skeletal muscle fiber types by salvianic acid A
sodium, which comprises the following steps: S1,
small molecule drugs, S2, C2C12
cell culture and treatment, S3, mouse treatment, S4, measurement of
grip strength and exercise tolerance, S5, evaluation of
oxygen consumption, S6,
RNA extraction and real-time fluorescent quantitative PCR (qPCR), S7, Westernblot, and S8, immunofluorescent
staining.
Sodium tanshinol adjusts expression of related genes of
muscle fiber types, so that conversion of
muscle fibers from glycolytic
muscle fibers to oxidized muscle fibers is promoted, and understanding of
sodium tanshinol on a
molecular mechanism of muscle
fiber type formation and conversion is deepened.